SD

Smita Datta

Director Director DIN 08429258
DIN 08429258 First appointment Apr 2019 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Apr 2019
Shareholding value Locked Premium profile

About Smita Datta

Data last updated:

Smita Datta has 7 years in corporate governance. Formerly with 1 company, such as Curophil Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08429258
Primary Designation Director
First Appointment 03 Apr 2019
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Curophil Pharma Private Limited U51397MH2018PTC318532
Director03 Apr 20192018Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Curophil Pharma Private Limited
Premium access

Shareholding and investment profile for Smita Datta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Smita Datta

Smita Datta has 7 years in corporate governance. Formerly with 1 company, such as Curophil Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Smita Datta is associated with 0 companies as a director.

Smita Datta has expertise in General Business.

Smita Datta has 7 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available